Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unexpected Diffuse Alveolar Hemorrhage After Bronchoscopy.
Tsukida S, Watanabe S, Hongo M, Murase Y, Yamamoto Y, Kase K, Terada N, Koba H, Tambo Y, Yano S. Tsukida S, et al. Among authors: tambo y. Chest. 2023 Sep;164(3):e71-e74. doi: 10.1016/j.chest.2023.04.027. Chest. 2023. PMID: 37689476
A Single Institution Retrospective Study of the Clinical Efficacy of Tiotropium Respimat in Never-Smoking Elderly Asthmatics with Irreversible Airflow Limitation.
Hara J, Kasahara K, Ohkura N, Yamamura K, Sakai T, Abo M, Ogawa N, Saeki K, Koba H, Watanabe S, Uchida Y, Tambo Y, Sone T, Kimura H. Hara J, et al. Among authors: tambo y. Drug Res (Stuttg). 2019 Apr;69(4):211-217. doi: 10.1055/a-0665-4379. Epub 2018 Sep 7. Drug Res (Stuttg). 2019. PMID: 30193393
The prevalence and clinical features of asthma-COPD overlap (ACO) definitively diagnosed according to the Japanese Respiratory Society Guidelines for the Management of ACO 2018.
Yamamura K, Hara J, Kobayashi T, Ohkura N, Abo M, Akasaki K, Nomura S, Yuasa M, Saeki K, Terada N, Matsuoka H, Tambo Y, Nishikawa S, Sone T, Kimura H, Kasahara K. Yamamura K, et al. Among authors: tambo y. J Med Invest. 2019;66(1.2):157-164. doi: 10.2152/jmi.66.157. J Med Invest. 2019. PMID: 31064931 Free article.
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer.
Kimura H, Araya T, Yoneda T, Shirasaki H, Kurokawa K, Sakai T, Koba H, Tambo Y, Nishikawa S, Sone T, Kasahara K. Kimura H, et al. Among authors: tambo y. Cancer Commun (Lond). 2019 Nov 21;39(1):78. doi: 10.1186/s40880-019-0423-3. Cancer Commun (Lond). 2019. PMID: 31753015 Free PMC article. No abstract available.
40 results